Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in acute ischemic stroke
ACTRN12612000957897Phase 2Not yet recruiting
- Sponsor
- Monash University
- Start
- Oct 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of exenatide in ischemic stroke (2 arms), sponsored by Monash University. Primary endpoint: Glycemic control. Planned start Oct 2012; status: not yet recruiting.
02
Drugs
exenatide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ACTRN12612000957897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000957897.